8 General Notices/Errata

  • GENERAL NOTICES/ERRATA
    Vol. 29 Iss. 3 - October 08, 2012

    GENERAL NOTICES/ERRATA

    STATE CORPORATION COMMISSION

    Bureau of Insurance

    September 14, 2012

    Administrative Letter 2012-09

    TO: All Carriers Licensed to Market Credit Life Insurance or Credit Accident and Sickness Insurance in Virginia and Interested Parties

    RE: Credit Life Insurance and Credit Accident and Sickness Insurance Premium Rates

    Effective January 1, 2013

    On July 26, 2012, the Virginia State Corporation Commission (the "Commission") issued an Order Adopting Adjusted Prima Facie Rates for the Triennium Commencing January 1, 2013, Case No. INS-2012-00014. All insurers licensed to market credit life insurance or credit accident and sickness insurance in Virginia were mailed a copy of the Order and the adopted rates on August 2, 2012. Pursuant to § 38.2-3725 D and E of the Code of Virginia, the adjusted prima facie rates for the triennium commencing January 1, 2013 will remain in effect until January 1, 2016.

    Each company marketing credit life insurance or credit accident and sickness insurance in Virginia must submit the rates and refund formulas applicable to the upcoming triennium to the Bureau for approval. Each filing should include the following information:

    • The specific single premium and monthly outstanding balance (MOB) rates and rate formulas, and examples of the rate formulas;

    • All refund formulas, including examples;

    • Any other information required to document the development of the rates and refund formulas;

    • The date of previously approved formulas;

    • The form number to which each rate or formula will apply; and

    • A description of the referenced forms.

    A request for approval of a deviated premium rate or rates to be effective on or after January 1, 2013 may be included as part of the filing referenced above. It should be noted that previously approved deviated premium rates can only be used through December 31, 2012, in accordance with § 38.2-3728 C 1 of the Code of Virginia.

    The filing requirements for credit life insurance and credit accident and sickness insurance filings may be found on the Bureau's website at: http://www.scc.virginia.gov/division/boi/co/health/lh_check.aspx

    My staff will review filings as promptly as possible; however, companies that delay making filings after December 1, 2012 cannot be assured that our review will be completed by January 1, 2013. Any insurer that has not received the Bureau's approval of its rates and refund formulas on or before January 1, 2013 must cease marketing credit life insurance or credit accident and sickness insurance in Virginia as of January 1, 2013 and must cease charging premiums for existing MOB contracts as of January 1, 2013 until such date that it has received the Commission's approval, as noted above.

    Any questions with regards to any of the above matters should be directed to Amanda G. McCauley, Senior Insurance Market Examiner, Life and Health Division, telephone (804) 371-0034, or email amanda.mccauley@scc.virginia.gov.

    /s/ Jacqueline K. Cunningham
    Commissioner of Insurance

    DEPARTMENT OF ENVIRONMENTAL QUALITY

    Notice of Bacteria TMDL Modification of Lower Mattaponi, Lower Pamunkey, and Upper York Rivers in King William, New Kent, and King and Queen Counties and the Town of West Point

    The Department of Environmental Quality (DEQ) seeks public comment from interested persons on 25 proposed modifications of the Total Maximum Daily Loads (TMDLs) developed for impaired segments of the Lower Mattaponi River (VAP-F25E-01), Lower Pamunkey River (VAP-F14E-03), and the Upper York River (VAP-F26E-05 and VAP-F26E-20). The TMDL was approved by the Environmental Protection Agency on July 28, 2010 and is available at: http://www.deq.virginia.gov/portals/0/DEQ/Water/TMDL/apptmdls/yorkrvr/yorkpamunkmatta.pdf. To view the proposed revised TMDL pages and the modification letter to EPA explaining each intended modification along with page numbers modified, please visit: http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs/TMDL/TMDLDevelopment/DocumentationforSelectTMDLs.aspx. The proposed modifications were first public noticed this past August and a minimum 30-day public comment period was observed. DEQ has provided an additional public comment opportunity from October 8, 2012, through November 9, 2012, to allow interested persons additional time to comment and review proposed TMDL modifications.

    Changes 1-5 are with regard to the Lower Mattaponi River Enterococci TMDL segment (VAP-F25E-01).

    (1) A Single Family Home - General Permit (VAG404212) discharges ≤1000 gallons per day (GPD) to a non-tidal tributary of the Lower Pamunkey River, called Un-named Tributary (UT) to Olsson's Pond, was mistakenly given a waste load allocation (WLA) based on 60 GPD (or 0.00006


    million gallons per day (MGD)) in the Lower Mattaponi River Enterococci (recreational use) TMDL. The facility should have been allocated in the Lower Pamunkey River Enterococci TMDL. DEQ proposes to correct the Lower Mattaponi TMDL by removing the waste load allocation for Enterococci. This load will be moved to future growth and may be used by future permittees in this segment. The details regarding the re-allocation of the WLA for this permittee within the Lower Pamunkey segment and how the facility will maintain compliance with the Lower Pamunkey River TMDL are noted in the section below.

    (2) The Hampton Roads Sanitation District (HRSD) West Point Sewage Treatment Plant (STP) (VA0075434) is a VPDES minor municipal plant with a design flow of 0.60 million gallons per day (MGD) which discharges to the Lower Mattaponi River. The WLA in the TMDL was based on the Single Sample Instantaneous Maximum standard of 104 (cfu/100mL) Enterococci, when it should have been based on the geometric mean (GM) standard of 35 (cfu/100mL) Enterococci. The geometric mean standard is the appropriate standard and results in a smaller WLA for Enterococci for the facility. DEQ proposes to correct the Lower Mattaponi River Enterococci TMDL by revising the facility's WLA to accommodate this facility at a maximum design flow of 0.60 MGD and an Enterococci GM standard of 35 cfu/100mL.

    (3) The original Future Growth amount was equal to five times the load of municipal discharger HRSD West Point (VA0075434), based on the Single Sample Instantaneous Maximum Standard of 104 cfu/100mL Enterococci. This was equal to 0.01% of the TMDL, which is inadequate to address potential future permitting needs of this segment. DEQ proposes to increase the Future Growth value to 0.76% of the TMDL.

    (4) The revisions noted in 1-3 above, result in an increase in the Total WLA and a decrease in the Load Allocation (LA) values.

    (5) Finally, DEQ has added tables within the TMDL document to reflect both the Annual and Daily WLA, LA, and TMDL values for the Lower Mattaponi River Enterococci TMDL.

    In summary, the changes noted above were necessary to correct TMDL development errors, address insufficient future growth values for future permitting needs, and to express the loadings in both annual and daily values as required by EPA.

    Changes 6-11 are with regard to the Lower Pamunkey River Enterococci TMDL segment (VAP-F14E-03).

    (6) A Single Family Home - General Permit (VAG404212) discharges ≤1000 gallons per day (GPD) to a non-tidal tributary of the Lower Pamunkey River, Un-named Tributary (UT) to Olssen's Pond. This permit was mistakenly given a waste load allocation (WLA) based on 60 GPD (or 0.00006 million gallons per day (MGD)) in the Lower Mattaponi River Enterococci (recreational use) TMDL, but should have been allocated in the Lower Pamunkey River Enterococci TMDL. DEQ proposes to allocate a WLA for this facility in the Lower Pamunkey Enterococci TMDL. This is a facility which uses chlorination in a contact tank, followed by dechlorination, meets Virginia's Single Family Home - General Permit limits for discharges to non-tidal freshwater, and the facility outfall is located more than 2.75 miles upstream of the Enterococci impairment on the Lower Pamunkey River mainstem. Compliance of this facility with the WLA for Enterococci will be met through compliance with existing E. coli permit limit protections. Compliance of this facility with the existing permit limits will neither cause nor contribute to the downstream Enterococci bacteria impairment in the Lower Pamunkey River.

    (7) Parham Landing Waste Water Treatment Plant (WWTP) (VA0088331) is a VPDES major municipal plant with a design flow of 2 MGD. However, the WLA in the Lower Pamunkey River Enterococci TMDL was based on the Single Sample Instantaneous Maximum standard of 104 (cfu/100mL) Enterococci, when it should have been based on the geometric mean (GM) standard of 35 (cfu/100mL) Enterococci. The WLA was also allocated at the incorrect design flow of 0.568 MGD. DEQ proposes to revise the Lower Pamunkey Enterococci TMDL by correcting the facility's WLA to accommodate this facility at a maximum design flow of 2 MGD and an Enterococci GM standard of 35 cfu/100mL.  While the geometric mean standard reduced the WLA, the correct design flow of the facility increased it; however, DEQ believes compliance of this facility with the existing permit limit will neither cause nor contribute to the Enterococci bacteria impairment in the Lower Pamunkey River.

    (8) The Rock-Tenn West Point Mill (VA0003115) is a VPDES major industrial facility with a design flow of 23 MGD which discharges to the Lower Pamunkey River. This facility was recently identified as a source of bacteria in the Lower Pamunkey River and should receive an allocation in the Enterococci TMDL. DEQ proposes to correct the Lower Pamunkey River Enterococci TMDL by allocating a WLA to accommodate this facility at a maximum design flow of 23 MGD and the Enterococci GM standard of 35 cfu/100mL. This facility's permit is currently under permit review, will include a limit based on the Enterococci geometric mean standard (35 cfu/100ml) and is expected to be public noticed and reissued later this year. The permit will include a compliance schedule to ensure the bacteria limits for Enterococci are met. Compliance of this facility with the Enterococci permit limit will neither cause nor contribute to the impairment in the Lower Pamunkey River.

    (9) The original Future Growth allocated was equal to five times the load of the municipal discharger, Parham Landing


    WWTP (VA0088331) at the Single Sample Instantaneous Maximum standard of 104 cfu/100mL Enterococci. This is equal to 0.01% of the TMDL, which is inadequate to address potential future permitting needs of this segment. DEQ proposes to increase the Future Growth to 0.74% of the TMDL.

    (10) The revisions noted in 6-9 above, result in an increase in the Total WLA and a decrease in the Load Allocation (LA) values.

    (11) Finally, DEQ has added tables within the TMDL document to reflect both the Annual and Daily WLA, LA, and TMDL values for the Lower Pamunkey River Enterococci TMDL. 

    In summary, the changes noted above were necessary to correct TMDL development errors, include a WLA for a newly identified bacteria source, address insufficient future growth values for future permitting needs, and express the loadings in both annual and daily values as required by EPA.

    Changes 12-18 are with regard to the Upper York River Enterococci TMDL segment (VAP-F26E-05).

    (12) A Single Family Home - General Permit (VAG404212) discharges ≤1000 gallons per day (GPD) to a non-tidal tributary of the Lower Pamunkey River, Un-named Tributary (UT) to Olsson's Pond. This facility should have received a WLA in the Upper York River segment in order to account for incoming load because sources in the Lower Pamunkey River Enterococci TMDL were used as inputs in the Upper York Enterococci TMDL development. DEQ proposes to allocate a WLA for this facility in the Upper York Enterococci TMDL, based on the geometric mean (GM) (35 cfu/100ml) standard. This is a facility which uses chlorination in a contact tank, followed by dechlorination, meets Virginia's Single Family Home - General Permit limits for discharges to non-tidal freshwater, and the facility outfall is greater than 5 miles upstream of the Upper York River Enterococci impairment. Compliance of this facility with the daily WLA for Enterococci will be met through compliance with existing E. coli permit limit protections. Compliance of this facility with the existing permit limits will neither cause nor contribute to the downstream Enterococci bacteria impairment in the Upper York River.

    (13) The HRSD West Point STP (VA0075434) is a VPDES minor municipal plant with a design flow of 0.60 million gallons per day (MGD) which discharges to the Lower Mattaponi River. The WLA in the TMDL was based on the Single Sample Instantaneous Maximum standard of 104 (cfu/100mL) Enterococci, when it should have been based on the geometric mean (GM) standard of 35 (cfu/100mL) Enterococci. The geometric mean standard is the appropriate standard and results in a smaller WLA for Enterococci for the facility. DEQ proposes to correct the Upper York River Enterococci TMDL by revising the facility's WLA to accommodate this facility at a maximum design flow of 0.60 MGD and the Enterococci GM standard of 35 cfu/100mL. Compliance of this facility with the existing permit limits will neither cause nor contribute to the downstream Enterococci bacteria impairment in the Upper York River.

    (14) Parham Landing WWTP (VA0088331) is a VPDES major municipal plant with a design flow of 2 MGD. However, the facility's WLA in the Upper York River Enterococci TMDL was based on the Single Sample Instantaneous Maximum standard of 104 (cfu/100mL) Enterococci, when it should have been based on the geometric mean (GM) standard of 35 (cfu/100mL) Enterococci. The WLA was also allocated at the incorrect design flow of 0.568 MGD.  DEQ proposes to correct the Upper York River Enterococci TMDL by revising the facility's WLA to accommodate this facility at a maximum design flow of 2 MGD and the Enterococci GM standard of 35 cfu/100mL.  While the geometric mean standard reduced the WLA, the correct design flow of the facility increased it; however, DEQ believes compliance of this facility with the existing permit limit will neither cause nor contribute to the Enterococci bacteria impairment in the Upper York River.

    (15) The Rock-Tenn West Point Mill (VA0003115) is a VPDES major industrial facility with a design flow of 23 MGD which discharges to the Lower Pamunkey River.  This facility was recently identified as a source of bacteria in the Lower Pamunkey River and should receive a WLA in the Upper York segment to account for the incoming load because sources in the Lower Pamunkey River Enterococci TMDL were used as inputs in the Upper York Enterococci TMDL development. DEQ proposes to revise the Upper York Enterococci TMDL by allocating a WLA to accommodate this facility at a maximum design flow of 23 MGD and the Enterococci GM standard of 35 cfu/100mL. This facility's permit is currently under permit review, will include a limit based on the Enterococci geometric mean standard (35 cfu/100ml) and is expected to be public noticed and reissued later this year. The permit will include a compliance schedule to ensure the bacteria limits for Enterococci are met. Compliance of this facility with the Enterococci permit limit will neither cause nor contribute to the impairment in the Upper York River.

    (16) The original Future Growth allocated was equal to the sum of five times the load of the municipal dischargers HRSD West Point STP (VA0075434) and Parham Landing WWTP (VA0088331) at the Single Sample Instantaneous Maximum standard of 104 cfu/100mL Enterococci, equal to 0.01% of the TMDL, which is inadequate to address potential future permitting needs of this segment. DEQ proposes to increase the Future Growth to 0.75% of the TMDL.

    (17) The revisions noted in 12-16 above, result in an increase in the Total WLA and a decrease in the Load Allocation (LA) values.

    (18) Finally, DEQ has added tables within the TMDL document to reflect both the Annual and Daily WLA, LA, and TMDL values for the Upper York River Enterococci TMDL.

    In summary, the changes noted above were necessary to correct TMDL development errors, include a WLA for a newly identified bacteria source, address insufficient future growth values for future permitting needs, and to express the loadings in both annual and daily values as required by EPA.

    Changes 19-25 are with regard to the Upper York River Fecal Coliform TMDL segment (VAP-F26E-20).

    (19) A Single Family Home - General Permit (VAG404212) discharges ≤1000 gallons per day (GPD) to a non-tidal tributary of the Lower Pamunkey River, Un-named Tributary (UT) to Olsson's Pond. The facility received a WLA in the Upper York River Fecal Coliform (shellfish) TMDL based on the 90th Percentile Fecal Coliform Standard of 49 Most Probable Number (MPN) per 100mL when it should have been based on a 200 MPN/100mL, which is the concentration used to model protective areas below dischargers to shellfish growing areas by the Virginia Department of Health. The WLA was also based on the incorrect design flow of the facility 60 GPD (or 0.00006 million gallons per day (MGD)). DEQ proposes to correct the Upper York River Fecal Coliform TMDL by revising the WLA at a design flow of 1000 GPD and a Fecal Coliform concentration of 200 MPN/100mL. This is a facility which uses chlorination in a contact tank, followed by dechlorination, meets Virginia's Single Family Home - General Permit limits for discharges to non-tidal freshwater, and the facility outfall is greater than 5 miles upstream of the Upper York River Fecal Coliform impairment. Compliance of this facility with the WLA for Fecal Coliform will be met through compliance with existing E. coli permit limit protections. Compliance of this facility with the existing permit limits will neither cause nor contribute to the downstream Fecal Coliform impairment in the Upper York River.

    (20) The HRSD West Point STP (VA0075434) is a VPDES minor municipal plant with a design flow of 0.60 million gallons per day (MGD) which discharges to the Lower Mattaponi River.  The facility should have received a WLA for Fecal Coliform based on 200 MPN/100mL, which is the concentration used to model protective areas below dischargers to shellfish growing areas by the Virginia Department of Health. DEQ proposes to correct the Upper York River Fecal Coliform TMDL by allocating a WLA to accommodate this facility at a maximum design flow of 0.60 MGD and a Fecal Coliform concentration of 200 MPN/100mL. Compliance of this facility with the existing permit limits for fecal coliform will neither cause nor contribute to the downstream Fecal Coliform impairment in the Upper York River.

    (21) Parham Landing WWTP (VA0088331) is a VPDES major municipal plant with a design flow of 2 MGD which discharges to the Lower Pamunkey River. The facility should have received a WLA for Fecal Coliform based on 200 MPN/100mL, which is the concentration used to model protective areas below dischargers to shellfish growing areas by the Virginia Department of Health. DEQ proposes to correct the Upper York River Fecal Coliform TMDL by allocating a WLA to accommodate this facility at a maximum design flow of 2 MGD and a Fecal Coliform concentration of 200 MPN/100mL. The facility has an existing permit limit for Enterococci to meet the current Water Quality Standard for recreational use. Due to the protectiveness of the Enterococci discharge limits and the outfall location, which is over 5.5 miles upstream of the Upper York River shellfish impairment for Fecal Coliform, compliance of this facility with the Upper York Fecal Coliform WLA will be met through the existing Enterococci permit limit protections. Compliance of this facility with the existing permit limits will neither cause nor contribute to the downstream Fecal Coliform bacteria impairment in the Upper York River.

    (22) The Rock-Tenn West Point Mill (VA0003115) is a VPDES major industrial facility with a design flow of 23 MGD which discharges to the Lower Pamunkey River. This facility was recently identified as a source of bacteria in the Lower Pamunkey River segment and should receive a WLA in the Upper York Fecal Coliform (shellfish) TMDL, as bacteria sources in the Lower Pamunkey River Enterococci TMDL were used as inputs in the Upper York Fecal Coliform (shellfish) TMDL development. DEQ proposes to revise the Upper York Fecal Coliform TMDL by allocating a WLA to accommodate this facility at a maximum design flow of 23 MGD and a Fecal Coliform concentration of 200 MPN/100mL. The facility's effluent is categorized as a non-sewage discharge containing Enterococci. The facility is receiving a WLA for Enterococci in both the Lower Pamunkey and Upper York Enterococci TMDLs (noted in above sections). Wood-pulp facilities have historically had an issue of false-positive results when analyzed for Fecal Coliform. Due to the nature of the discharge and protectiveness of the Enterococci discharge limits and given that the outfall is located over 1 mile upstream of the Upper York shellfish impairment for fecal coliform, compliance of this facility with the Upper York Fecal Coliform WLA will be met through the existing Enterococci permit limit protections. This facility's permit is currently under permit review, will include a limit based on the Enterococci geometric mean standard (35 cfu/100ml) and is expected to be public noticed and reissued later this year. The permit will include a compliance schedule to ensure the bacteria limits for Enterococci are met. Compliance of this facility with the existing permit limits is not expected to cause or contribute to the downstream Fecal Coliform bacteria impairment in the Upper York River.

    (23) The original Future Growth allocated was equal to 1.0% of the TMDL. DEQ proposes to increase the daily Future Growth to 1.6% of the TMDL, which will more adequately address potential future permitting needs of this segment.

    (24) The revisions noted in 19-23 above, result in an increase in the Total WLA and a decrease in the Load Allocation (LA) values.

    (25) Finally, DEQ has added tables within the TMDL document to reflect both the Annual and Daily WLA, LA, and TMDL values for the Upper York River Fecal Coliform (shellfish) TMDL.

    In summary, the changes noted above were necessary to correct TMDL development errors, include a WLA for a newly identified bacteria source, address insufficient future growth values for future permitting needs, and express the loadings in both annual and daily values as required by EPA.

    The changes noted above to the Lower Mattaponi Enterococci, Lower Pamunkey Enterococci, York Enterococci and shellfish TMDLs are less than <1.0%, respectively for each TMDL and will neither cause nor contribute to the non-attainment of each impaired segment.

    The public comment period for these modifications will end on Friday November 9, 2012. Please send comments to Margaret Smigo, Department of Environmental Quality, Piedmont Regional Office, 4969-A Cox Road, Glen Allen, VA 23060, email margaret.smigo@deq.virginia.gov, or FAX (Attn. Margaret Smigo) at (804) 527-5106. Following the comment period, a modification letter and comments received will be sent to EPA for final approval. To request a copy of the full proposed TMDL modification, please see the link: http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs/TMDL/TMDLDevelopment/DocumentationforSelectTMDLs.aspx or contact Margaret Smigo.


    DEPARTMENT OF FORENSIC SCIENCE

    Approval of Field Tests for Detection of Drugs

    In accordance with 6VAC40-30, Regulations for the Approval of Field Tests for Detection of Drugs, and under the authority of the Code of Virginia, the following field tests for detection of drugs are approved field tests:

    O D V INCORPORATED

    13386 INTERNATIONAL PARKWAY

    JACKSONVILLE, FLORIDA 32218-2383

    ODV NarcoPouch

    Drug or Drug Type:

    Manufacturer's Field Test:

    Heroin

    902 – Marquis Reagent

    Amphetamine

    902 – Marquis Reagent

    Methamphetamine

    902 – Marquis Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    902 – Marquis Reagent

    Cocaine Hydrochloride

    904 or 904B – Cocaine HCl and Base Reagent

    Cocaine Base

    904 or 904B – Cocaine HCl and Base Reagent

    Barbiturates

    905 – Dille-Koppanyi Reagent

    Lysergic Acid Diethylamide (LSD)

    907 – Ehrlich's (Modified) Reagent

    Marijuana

    908 – Duquenois – Levine Reagent

    Hashish Oil

    908 – Duquenois – Levine Reagent

    Marijuana

    909 – K N Reagent

    Hashish Oil

    909 – K N Reagent

    Phencyclidine (PCP) Reagent

    914 – PCP Methaqualone

    Heroin

    922 – Opiates Reagent

    Methamphetamine

    923 – Methamphetamine/Ecstasy Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    923 – Methamphetamine/Ecstasy Reagent

    Heroin

    924 – Mecke's (Modified) Reagent

    Diazepam

    925 – Valium/Ketamine Reagent

    Ketamine

    925 – Valium/Ketamine Reagent

    Ephedrine

    927 – Ephedrine Reagent

    gamma – Hydroxybutyrate (GHB)

    928 – GHB Reagent

    ODV NarcoTest

    Drug or Drug Type:

    Manufacturer's Field Test:

    Heroin

    7602 – Marquis Reagent

    Amphetamine

    7602 – Marquis Reagent

    Methamphetamine

    7602 – Marquis Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    7602 – Marquis Reagent

    Barbiturates

    7605 – Dille-Koppanyi Reagent

    Lysergic Acid Diethylamide (LSD)

    7607 – Ehrlich's (Modified) Reagent

    Marijuana

    7608 – Duquenois Reagent

    Hashish Oil

    7608 – Duquenois Reagent

    Marijuana

    7609 – K N Reagent

    Hashish Oil

    7609 – K N Reagent

    Cocaine Hydrochloride

    7613 – Scott (Modified) Reagent

    Cocaine Base

    7613 – Scott (Modified) Reagent

    Phencyclidine (PCP)

    7614 – PCP Methaqualone Reagent

    Heroin

    7622 – Opiates Reagent

    Methamphetamine

    7623– Methamphetamine/Ecstasy Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    7623– Methamphetamine/Ecstasy Reagent

    Heroin

    7624 – Mecke's Reagent

    Diazepam

    7625 – Valium/Ketamine Reagent

    Ketamine

    7625 – Valium/Ketamine Reagent

    Ephedrine

    7627 – Chen's Reagent - Ephedrine

    gamma – Hydroxybutyrate (GHB)

    7628 – GHB Reagent

    SIRCHIE FINGERPRINT LABORATORIES

    100 HUNTER PLACE

    YOUNGSVILLE, NORTH CAROLINA 27596

    NARK

    Drug or Drug Type:

    Manufacturer's Field Test:

    Narcotic Alkaloids

    1 – Mayer's Reagent

    Heroin

    1 – Mayer's Reagent

    Morphine

    1 – Mayer's Reagent

    Amphetamine

    1 – Mayer's Reagent

    Methamphetamine

    1 – Mayer's Reagent

    Opium Alkaloids

    2 – Marquis Reagent

    Heroin

    2 – Marquis Reagent

    Morphine

    2 – Marquis Reagent

    Amphetamine

    2 – Marquis Reagent

    Methamphetamine

    2 – Marquis Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    2 – Marquis Reagent

    Meperidine (Demerol) (Pethidine)

    2 – Marquis Reagent

    Heroin

    3 – Nitric Acid

    Morphine

    3 – Nitric Acid

    Cocaine Hydrochloride

    4 – Cobalt Thiocyanate Reagent

    Cocaine Base

    4 – Cobalt Thiocyanate Reagent

    Procaine

    4 – Cobalt Thiocyanate Reagent

    Tetracaine

    4 – Cobalt Thiocyanate Reagent

    Barbiturates

    5 – Dille-Koppanyi Reagent

    Heroin

    6 – Mandelin Reagent

    Morphine

    6 – Mandelin Reagent

    Amphetamine

    6 – Mandelin Reagent

    Methamphetamine

    6 – Mandelin Reagent

    Lysergic Acid Diethylamide (LSD)

    7 – Ehrlich's Reagent

    Marijuana

    8 – Duquenois Reagent

    Hashish

    8 – Duquenois Reagent

    Hashish Oil

    8 – Duquenois Reagent

    Tetrahydrocannabinol (THC)

    8 – Duquenois Reagent

    Marijuana

    9 – NDB (Fast Blue B Salt) Reagent

    Hashish

    9 – NDB (Fast Blue B Salt) Reagent

    Hashish Oil

    9 – NDB (Fast Blue B Salt) Reagent

    Tetrahydrocannabinol (THC)

    9 – NDB (Fast Blue B Salt) Reagent

    Cocaine Base

    13 – Cobalt Thiocyanate/Crack Test

    NARK II

    Drug or Drug Type:

    Manufacturer's Field Test:

    Narcotic Alkaloids

    01 – Marquis Reagent

    Heroin

    01 – Marquis Reagent

    Morphine

    01 – Marquis Reagent

    Amphetamine

    01 – Marquis Reagent

    Methamphetamine

    01 – Marquis Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    01 – Marquis Reagent

    Morphine

    02 – Nitric Acid

    Heroin

    02 – Nitric Acid

    Barbiturates

    03 – Dille-Koppanyi Reagent

    Lysergic Acid Diethylamide (LSD)

    04 – Ehrlich's Reagent

    Marijuana

    05 – Duquenois – Levine Reagent

    Hashish

    05 – Duquenois – Levine Reagent

    Hashish Oil

    05 – Duquenois – Levine Reagent

    Tetrahydrocannabinol (THC)

    05 – Duquenois – Levine Reagent

    Cocaine Hydrochloride

    07 – Scott's (Modified) Reagent

    Cocaine Base

    07 – Scott's (Modified) Reagent

    Phencyclidine (PCP)

    09 – Phencyclidine Reagent

    Opiates

    10 – Opiates Reagent

    Heroin

    10 – Opiates Reagent

    Morphine

    10 – Opiates Reagent

    Heroin

    11 – Mecke's Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    11 – Mecke's Reagent

    Pentazocine

    12 – Talwin/ Pentazocine Reagent

    Ephedrine

    13 – Ephedrine Reagent

    Diazepam

    14 – Valium Reagent

    Methamphetamine

    15 – Methamphetamine (Secondary Amines Reagent)

    Narcotic Alkaloids

    19 – Mayer's Reagent

    Heroin

    19 – Mayer's Reagent

    Morphine

    19 – Mayer's Reagent

    Amphetamine

    19 – Mayer's Reagent

    Methamphetamine

    19 – Mayer's Reagent

    3,4-Methylenedioxypyrovalerone (MDPV)

    24 – MDPV (Bath Salts) Reagent

    4-Methylmethcathinone (Mephedrone)

    25 – Mephedrone (Bath Salts) Reagent

    ARMOR HOLDINGS, INCORPORATED

    13386 INTERNATIONAL PARKWAY

    JACKSONVILLE, FLORIDA 32218-2383

    NIK

    Drug or Drug Type:

    Manufacturer's Field Test:

    Heroin

    Test A 6071 – Marquis Reagent

    Amphetamine

    Test A 6071 – Marquis Reagent

    Methamphetamine

    Test A 6071 – Marquis Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    Test A 6071 – Marquis Reagent

    Morphine

    Test B 6072 – Nitric Acid Reagent

    Barbiturates

    Test C 6073 – Dille-Koppanyi Reagent

    Lysergic Acid Diethylamide (LSD)

    Test D 6074 – LSD Reagent System

    Marijuana

    Test E 6075 – Duquenois – Levine Reagent

    Hashish Oil

    Test E 6075 – Duquenois – Levine Reagent

    Tetrahydrocannabinol

    Test E 6075 – Duquenois – Levine Reagent

    Cocaine Hydrochloride

    Test G 6077 – Scott (Modified) Reagent

    Cocaine Base

    Test G 6077 – Scott (Modified) Reagent

    Cocaine Hydrochloride

    6500 or 6501 – Cocaine ID Swab

    Cocaine Base

    6500 or 6501 – Cocaine ID Swab

    Phencyclidine (PCP)

    Test J 6079 – PCP Reagent System

    Heroin

    Test K 6080 – Opiates Reagent

    Heroin

    Test L 6081 – Brown Heroin Reagent System

    gamma – Hydroxybutyrate (GHB)

    Test O 6090 – GHB Reagent

    Ephedrine

    Test Q 6085 – Ephedrine Reagent

    Pseudoephedrine

    Test Q 6085 – Ephedrine Reagent

    Diazepam

    Test R 6085 – Valium Reagent

    Methamphetamine

    Test U 6087 – Methamphetamine Reagent

    3,4–Methylenedioxymethamphetamine (MDMA)

    Test U 6087 – Methamphetamine Reagent

    Methadone

    Test W 6088 – Mandelin Reagent System

    MISTRAL SECURITY INCORPORATED

    7910 WOODMONT AVENUE SUITE 820

    BETHESDA, MARYLAND 20814

    Drug or Drug Type:

    Manufacturer's Field Test:

    Heroin

    Detect 4 Drugs Aerosol

    Amphetamine

    Detect 4 Drugs Aerosol

    Methamphetamine

    Detect 4 Drugs Aerosol

    Marijuana

    Detect 4 Drugs Aerosol

    Hashish Oil

    Detect 4 Drugs Aerosol

    Methamphetamine

    Meth 1 and 2 Aerosol

    Heroin

    Herosol Aerosol

    Marijuana

    Cannabispray 1 and 2 Aerosol

    Hashish Oil

    Cannabispray 1 and 2 Aerosol

    Cocaine Hydrochloride

    Coca-Test Aerosol

    Cocaine Base

    Coca-Test Aerosol

    Marijuana

    Pen Test – D4D

    Phencyclidine

    Pen Test – D4D

    Amphetamine

    Pen Test – D4D

    Ketamine

    Pen Test – D4D

    Methamphetamine

    Pen Test – D4D

    Ephedrine

    Pen Test – D4D

    Heroin

    Pen Test – D4D

    Methadone

    Pen Test – D4D

    Buprenorphine

    Pen Test – D4D

    Opium

    Pen Test – D4D

    Phenobarbital

    Pen Test – Barbitusol

    Marijuana

    Pen Test – Cannabis Test

    Phencyclidine

    Pen Test – Coca Test

    Cocaine Hydrochloride

    Pen Test – Coca Test

    Cocaine base

    Pen Test – Coca Test

    Buprenorphine

    Pen Test – C&H Test

    Cocaine Hydrochloride

    Pen Test – C&H Test

    Cocaine base

    Pen Test – C&H Test

    Ephedrine

    Pen Test – C&H Test

    Ketamine

    Pen Test – C&H Test

    Heroin

    Pen Test – C&H Test

    Lysergic Acid Diethylamide (LSD)

    Pen Test – C&H Test

    Methadone

    Pen Test – C&H Test

    Methamphetamine

    Pen Test – C&H Test

    Heroin

    Pen Test – Herosol

    Methadone

    Pen Test – Herosol

    Lysergic Acid Diethylamide

    Pen Test – LSD Test

    Methamphetamine

    Pen Test – Meth/X Test

    3,4-Methylenedioxymethamphetamine (MDMA)

    Pen Test – Meth/X Test

    Morphine

    Pen Test – Opiatest

    Opium

    Pen Test – Opiatest

    Diazepam

    Pen Test – BZO

    Ephedrine

    Pen Test – Ephedrine

    Pseudoephedrine

    Pen Test – Ephedrine

    JANT PHARMACAL CORPORATION

    16255 VENTURA BLVD., #505

    ENCINO, CA  91436

    Formerly available through:

    MILLENNIUM SECURITY GROUP

    Accutest IDenta

    Drug or Drug Type:

    Manufacturer's Field Test:

    Marijuana

    Marijuana/Hashish (Duquenois-Levine Reagent)

    Hashish Oil

    Marijuana/Hashish (Duquenois-Levine Reagent)

    Heroin

    Heroin Step 1 and Step 2

    Cocaine Hydrochloride

    Cocaine/Crack Step 1 and Step 2

    Cocaine Base

    Cocaine/Crack Step 1 and Step 2

    3,4–Methylenedioxymethamphetamine (MDMA)

    MDMA Step 1 and Step 2

    Methamphetamine

    Methamphetamine Step 1 and Step 2

    COZART PLC

    92 MILTON PARK

    ABINGDON, OXFORDSHIRE ENGLAND OX14 4RY

    Drug or Drug Type:

    Manufacturer's Field Test:

    Cocaine

    Cocaine Solid Field Test

    Lynn Peavey Company

    10749 West 84th Terrace

    Lexexa, KS 66214

    QuickCheck

    Drug or Drug Type:

    Manufacturer's Field Test:

    Marijuana

    Marijuana – 10120

    Marijuana

    Marijuana – 10121

    Hashish Oil

    Marijuana – 10120

    Hashish Oil

    Marijuana – 10121

    Heroin

    Marquis – 10123

    Heroin

    Heroin - 10125

    Cocaine Hydrochloride

    Cocaine – 10124

    Cocaine Base

    Cocaine – 10124

    Methamphetamine

    Meth/Ecstasy – 10122

    Methamphetamine

    Marquis – 10123

    MDMA

    Meth/Ecstasy – 10122

    MDMA

    Marquis – 10123

    M.M.C. INTERNATIONAL B.V.

    FRANKENTHALERSTRAAT 16-18

    4816 KA BREDA

    THE NETHERLANDS

    Drug or Drug Type:

    Manufacturer's Field Test:

    Heroin

    Opiates/Amphetamine Test (Ampoule)

    Morphine

    Opiates/Amphetamine Test (Ampoule)

    Amphetamine

    Opiates/Amphetamine Test (Ampoule)

    Methamphetamine

    Opiates/Amphetamine Test (Ampoule)

    Codeine

    Opiates/Amphetamine Test (Ampoule)

    Marijuana

    Cannabis Test (Ampoule)

    Hashish Oil

    Cannabis Test (Ampoule)

    Cocaine Hydrochloride

    Cocaine/Crack Test (Ampoule)

    Cocaine base

    Cocaine/Crack Test (Ampoule)

    Heroin

    Heroin Test (Ampoule)

    Ketamine

    Ketamine Test (Ampoule)

    Methadone

    Methadone Test (Ampoule)

    Methamphetamine

    Crystal Meth/XTC Test (Ampoule)

    3,4-Methylenedioxymethamphetamine (MDMA)

    Crystal Meth/XTC Test (Ampoule)

    Morphine

    M&H Test (Ampoule)

    Heroin

    M&H Test (Ampoule)

    Ephedrine

    Ephedrine HCL Test (Ampoule)

    Pseudoephedrine

    Ephedrine HCL Test (Ampoule)

    Pentazocine

    Pentazocine Test (Ampoule)

    Buprenorphine

    Buprenorphine HCL Test (Ampoule)

    Gamma butyrolactone (GBL)

    GBL Test (Ampoule)

    Gamma hydroxybutyric acid (GHB)

    GHB Test (Ampoule)

    Oxycodone

    Oxycodone Test (Ampoule)

    Oxymetholone

    Steroids Test B (Ampoule)

    Testosterone

    Steroids Test B (Ampoule)

    Methandrostenolone

    Steroids Test B (Ampoule)

    Phenylacetone

    PMK/BMK(BMK) Test (Ampoule)

    Lysergic Acid Diethylamide (LSD)

    LSD Test (Ampoule)

    Phencyclidine (PCP)

    PCP Test (Ampoule)

    Methaqualone

    Methaqualone Test (Ampoule)

    Amobarbital

    Barbiturates Test (Ampoule)

    Pentobarbital

    Barbiturates Test (Ampoule)

    Phenobarbital

    Barbiturates Test (Ampoule)

    Secobarbital

    Barbiturates Test (Ampoule)

    Propoxyphene

    Propoxyphene Test (Ampoule)

    Diazepam

    V&R Test (Ampoule)

    Cocaine Hydrochloride

    Cocaine/Crack Test (Spray)

    Cocaine base

    Cocaine/Crack Test (Spray)

    Cocaine Hydrochloride

    Cocaine Trace Wipes

    Cocaine base

    Cocaine Trace Wipes

    Morphine

    Opiate Cassette

    Heroin

    Opiate Cassette

    3,4-Methylenedioxymethamphetamine (MDMA)

    MDMA/Ecstasy Cassette

    Methamphetamine

    Methamphetamine Cassette

    Amphetamine

    Amphetamine Cassette


    STATE LOTTERY DEPARTMENT

    Director's Orders

    The following Director's Orders of the State Lottery Department were filed with the Virginia Registrar of Regulations on September 18, 2012. The orders may be viewed at the State Lottery Department, 900 East Main Street, Richmond, VA, or at the office of the Registrar of Regulations, 910 Capitol Street, 2nd Floor, Richmond, VA.

    Director's Order Number Ninety (12)

    Virginia Lottery's "HASBROTM" Official Sweepstakes Rules (effective September 7, 2012)

    Director's Order Number Ninety-Eight (12)

    Virginia Lottery's "Play for Keeps Sweeps" Official Sweepstakes Requirements (effective September 13, 2012)

    Director's Order Number One Hundred Two (12)

    "Seibert's Buy $5 Mega Millions Get Free Serious Java" Virginia Lottery Promotion Requirements (effective on the date of its signing and shall remain in full force and effect until ninety (90) days after the conclusion of the Incentive Program, unless otherwise extended by the Director.)

    STATE BOARD OF SOCIAL SERVICES

    Notice of Periodic Review

    Pursuant to Executive Order 14 (2010) and §§ 2.2-4007.1 and 2.2-4017 of the Code of Virginia, the Board of Social Services is conducting a periodic review of 22VAC40-12, Public Participation Guidelines.

    The review of this regulation will be guided by the principles in Executive Order 14 (2010) and § 2.2-4007.1 of the Code of Virginia.

    The purpose of this review is to determine whether this regulation should be terminated, amended, or retained in its current form. Public comment is sought on the review of any issue relating to this regulation, including whether the regulation (i) is necessary for the protection of public health, safety, and welfare or for the economical performance of important governmental functions; (ii) minimizes the economic impact on small businesses in a manner consistent with the stated objectives of applicable law; and (iii) is clearly written and easily understandable.

    The comment period begins October 8, 2012, and ends October 29, 2012.

    Comments may be submitted online to the Virginia Regulatory Town Hall at http://www.townhall.virginia.gov/L/Forums.cfm.

    Comments may also be sent to Karin Clark, Regulatory Coordinator, 801 East Main Street, Richmond, VA 23219, telephone (804) 726-7017, FAX (804) 726-7906, email karin.clark@dss.virginia.gov.

    Comments must include the commenter's name and address (physical or email) information in order to receive a response to the comment from the agency. Following the close of the public comment period, a report of the periodic review will be posted on the Town Hall and published in the Virginia Register of Regulations.

    Notice of Periodic Review

    Pursuant to Executive Order 14 (2010) and §§ 2.2-4007.1 and 2.2-4017 of the Code of Virginia, the State Board of Social Services is conducting a periodic review of 22VAC40-295, Temporary Assistance for Needy Families.

    The review of this regulation will be guided by the principles in Executive Order 14 (2010) and § 2.2-4007.1 of the Code of Virginia.

    The purpose of this review is to determine whether this regulation should be terminated, amended, or retained in its current form. Public comment is sought on the review of any issue relating to this regulation, including whether the regulation (i) is necessary for the protection of public health, safety, and welfare or for the economical performance of important governmental functions; (ii) minimizes the economic impact on small businesses in a manner consistent with the stated objectives of applicable law; and (iii) is clearly written and easily understandable.

    The comment period begins October 8, 2012, and ends October 29, 2012.

    Comments may be submitted online to the Virginia Regulatory Town Hall at http://www.townhall.virginia.gov/L/Forums.cfm. Comments may also be sent to Mark Golden, TANF Manager, 801 East Main Street, Richmond, VA 23219, telephone (804) 726-7385, FAX (804) 726-7357, or email mark.golden@dss.virginia.gov.

    Comments must include the commenter's name and address (physical or email) information in order to receive a response to the comment from the agency. Following the close of the public comment period, a report of the periodic review will be posted on the Town Hall and published in the Virginia Register of Regulations.

    STATE WATER CONTROL BOARD

    Consent Special Order for Dupont Teijin Films U.S. Limited Partnership

    An enforcement action has been proposed for DuPont Teijin Films U.S. Limited Partnership for alleged violations at DuPont Teijin Films, Hopewell Site at 3600 Discovery Drive, Chesterfield, VA. The State Water Control Board proposes to issue a consent special order to DuPont Teijin Films U.S. Limited Partnership to address noncompliance with State Water Control Board law. A description of the proposed action is available at the Department of Environmental Quality office named below or online at www.deq.virginia.gov. Gina Pisoni will accept comments by email at gina.pisoni@deq.virginia.gov, FAX (804) 527-5106, or postal mail Department of Environmental Quality, Piedmont Regional Office, 4949-A Cox Road, Glen Allen, VA 23060, from October 8, 2012, to November 8, 2012.

    VIRGINIA CODE COMMISSION

    Notice to State Agencies

    Contact Information: Mailing Address: Virginia Code Commission, 910 Capitol Street, General Assembly Building, 2nd Floor, Richmond, VA 23219; Telephone: Voice (804) 786-3591; FAX (804) 692-0625; Email: varegs@dls.virginia.gov.

    Meeting Notices: Section 2.2-3707 C of the Code of Virginia requires state agencies to post meeting notices on their websites and on the Commonwealth Calendar at http://www.virginia.gov/cmsportal3/cgi-bin/calendar.cgi.

    Cumulative Table of Virginia Administrative Code Sections Adopted, Amended, or Repealed: A table listing regulation sections that have been amended, added, or repealed in the Virginia Register of Regulations since the regulations were originally published or last supplemented in the print version of the Virginia Administrative Code is available at http://register.dls.virginia.gov/cumultab.htm.

    Filing Material for Publication in the Virginia Register of Regulations: Agencies use the Regulation Information System (RIS) to file regulations and related items for publication in the Virginia Register of Regulations. The Registrar's office works closely with the Department of Planning and Budget (DPB) to coordinate the system with the Virginia Regulatory Town Hall. RIS and Town Hall complement and enhance one another by sharing pertinent regulatory information.

    ERRATA

    STATE BOARD OF HEALTH

    Title of Regulation: 12VAC5-31. Virginia Emergency Medical Services Regulations.

    Publication: 29:1 VA.R. 32-103 September 10, 2012.

    Correction to Final Regulation:

    Page 91-92, 12VAC5-31-1552 A, replace

    "4. Complete a minimum of 12 hours of instructor focused continuing education.

    5. Submit an EMS education coordinator application to include endorsement from an EMS Physician."

    with

    "[ 4. Complete a minimum of 12 hours of instructor focused continuing education.

    5. 4. ] Submit an EMS education coordinator application to include endorsement from an EMS Physician."

    VA.R. Doc. No. R08-877; Filed September 20, 2012, 4:06 p.m.

Document Information